Deep Genomics

OverviewSuggest Edit

Deep Genomics develops a machine learning technology to understand how genetic variations lead to diseases. It develops an integrated computational system that could learn, predict and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The Company offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome.

HQToronto, CA

Latest Updates

Employees (est.) (Jan 2021)55(+4%)
Cybersecurity ratingAMore

Key People/Management at Deep Genomics

Brendan Frey

Brendan Frey

Founder & Chief Executive Officer

Deep Genomics Office Locations

Deep Genomics has an office in Toronto
Toronto, CA (HQ)
661 University Ave #480
Show all (1)

Deep Genomics Financials and Metrics

Summary Metrics

Founding Date


Deep Genomics total Funding

$56.7 m

Deep Genomics latest funding size

$40 m

Time since last funding

a year ago

Deep Genomics investors

Deep Genomics's latest funding round in January 2020 was reported to be $40 m. In total, Deep Genomics has raised $56.7 m
Show all financial metrics

Deep Genomics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Deep Genomics Online and Social Media Presence

Embed Graph

Deep Genomics News and Updates

Healthcare Artificial Intelligence Market Driven By iCarbonX, CloudMedx , Deep Genomics, Zephyr Health, Next IT Corp., IBM

The Insight Partners adds “Healthcare Artificial Intelligence Market Forecast to 2027 – COVID-19 Impact and Global Analysis” to its store providing analysis of the current and future market competition in the market. Insightful review of the key industry drivers, opportunities, barriers and challeng…

Today in hires: Deep Genomics, Flybits, Information Venture Partners

Three Canadian organizations have brought on new team members to add to their teams, including Deep Genomics, Flybits, and Information Venture Partners. Here’s a...

Today in hires: Traction Guest, TextNow, Deep Genomics, Perk Labs

Four Canadian companies have filled positions on their leadership teams. Here’s a breakdown of who is joining and what they bring to the table....

Deep Genomics raises $40 million Series B for AI drug discovery platform

Toronto-based AI therapeutics startup, Deep Genomics, has closed a $40 million Series B. This brings the company’s total funding to-date to $61 million. The...

BRIEF-Wave Life Sciences And Deep Genomics Form Collaboration To Discover Therapies For Genetic Neuromuscular Disorders


Deep Genomics lands $13 mln in follow-on round led by Khosla

Deep Genomics, a Toronto genetic medicine startup, has raised $13 million in follow-on financing. Khosla Ventures led the round and was joined by True Ventures, which led the company’s $5 million seed financing in 2015. Spun out of the University of Toronto in 2014, Deep Genomics is building a biolo…

Deep Genomics Frequently Asked Questions

  • When was Deep Genomics founded?

    Deep Genomics was founded in 2014.

  • Who are Deep Genomics key executives?

    Deep Genomics's key executives are Brendan Frey.

  • How many employees does Deep Genomics have?

    Deep Genomics has 55 employees.

  • Who are Deep Genomics competitors?

    Competitors of Deep Genomics include Acerta, Curai Health and Winterlight.

  • Where is Deep Genomics headquarters?

    Deep Genomics headquarters is located at 661 University Ave #480, Toronto.

  • Where are Deep Genomics offices?

    Deep Genomics has an office in Toronto.

  • How many offices does Deep Genomics have?

    Deep Genomics has 1 office.